Overview
Adam Mead practices practicing medicine in Oxford, United Kingdom.
Mr. Mead is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Bone Marrow Transplant, and Splenectomy.
He is actively involved in clinical research, co-authoring 153 peer reviewed articles and participating in 4 clinical trials.
Gender
Locations
Glasgow, SCT, United Kingdom
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Frequently Asked Questions about Adam J. Mead
Is Adam J. Mead a top-rated expert for Myelofibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Adam J. Mead is classified as an Elite expert for Myelofibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Adam J. Mead participate in research or clinical trials?
Yes. Adam J. Mead has published 153 articles and abstracts on conditions like Myelofibrosis. You can view a list of Adam J. Mead's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Essential Thrombocythemia
- MyelofibrosisMr. Mead isElite. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)
- Distinguished
- Polycythemia VeraMr. Mead isDistinguished. Learn about Polycythemia Vera.
- SplenomegalyMr. Mead isDistinguished. Learn about Splenomegaly.
- Advanced
- Aase SyndromeMr. Mead isAdvanced. Learn about Aase Syndrome.
- AnemiaMr. Mead isAdvanced. Learn about Anemia.
- Blood ClotsMr. Mead isAdvanced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)
- LeukemiaMr. Mead isAdvanced. Learn about Leukemia.
- ThrombocytopeniaMr. Mead isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Mr. Mead isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloid Leukemia (AML)Mr. Mead isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantMr. Mead isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaMr. Mead isExperienced. Learn about Burkitt Lymphoma.
- Chronic Myelomonocytic Leukemia (CMML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Myelodysplastic Syndrome (MDS)Mr. Mead isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaMr. Mead isExperienced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Pure Red Cell AplasiaMr. Mead isExperienced. Learn about Pure Red Cell Aplasia.
- RUNX1 Familial Platelet DisorderMr. Mead isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- SplenectomyMr. Mead isExperienced. Learn about Splenectomy.
- Transient Erythroblastopenia of Childhood